CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 8th, 2023 • Surface Oncology, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September 8, 2023 (this “Agreement”), is entered into by and among Coherus Biosciences, Inc., a Delaware corporation (“Parent”), and Computershare Inc., a Delaware corporation, (“Computershare”) and its affiliate Computershare Trust Company, N.A., a federally chartered trust company, jointly as rights agent (collectively, the “Rights Agent”).
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF SURFACE ONCOLOGY, LLC Dated this 8th day of September, 2023Limited Liability Company Agreement • September 8th, 2023 • Surface Oncology, Inc. • Biological products, (no disgnostic substances) • Delaware
This Limited Liability Company Agreement (this “Agreement”) of Surface Oncology, LLC (the “Company”) is made and entered into as of the date set forth above by Coherus BioSciences, Inc., a Delaware corporation, as the sole member of the Company (the “Member”).
